Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

1599 results found

2025 ∙ Wang, D. Zhang, F.

CKD-related impairment in humoral and cellular immune response and potential correlation with long COVID-19: a systematic review

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Boikos, C. Schaible, K. Nunez-Gonzalez, S. Welch, V. Hu, T. Kyaw, M. H. Choi, L. E. Kamar, J. Goebe, H. McLaughlin, J.

Co-Administration of BNT162b2 COVID-19 and Influenza Vaccines in Adults: A Global Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Influenza
  • Efficacy/effectiveness
  • Safety
  • Coverage
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Li, S. Li, R. Li, Y. Hu, Y. Liu, Y. Qin, J. Qin, Z. Feng, Q. Sheng, Z. Li, C. Peng, J.

Combination of Evans syndrome and COVID-19: a systematic review of reported cases

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Iannizzi, C. Andreas, M. Bohndorf, E. Hirsch, C. Zorger, A. M. Brinkmann-Paulukat, J. Bormann, B. Kaufman, J. Lischetzki, T. Monsef, I. Neufeind, J. Schmid-Kupke, N. Thole, S. Worbes, K. Skoetz, N.

Communication-based interventions to increase COVID-19 vaccine willingness and uptake: A systematic review with meta-analysis

  • All age groups
  • COVID-19
  • Coverage
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Wang, X. Pahwa, A. Bausch-Jurken, M. T. Chitkara, A. Sharma, P. Malmenas, M. Vats, S. Whitfield, M. G. Lai, K. Z. H. Dasari, P. Gupta, R. Nassim, M. Van de Velde, N. Green, N. Beck, E.

Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Adults with Underlying Medical Conditions: Systematic Literature Review and Pairwise Meta-Analysis Using GRADE

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Fahrbach, K. Cichewicz, A. Chu, H. Di Fusco, M. Burnett, H. Volkman, H. R. Akin-Fajiye, M. Mendoza, C. F. Cappelleri, J. C.

Comparative effectiveness of Omicron XBB 1.5-adapted COVID-19 vaccines: a systematic literature review and network meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Administration
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Syed, A. A. Eqbal, F. Shamsi, H. R. Syed, A. R. S. Zakir, S. J. Fawzy, M. Khan, K. S.

Comparative effectiveness of three common SARS-COV-2 vaccines: A network meta-analysis of randomized trials

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Moderate
2025 ∙ Rai, S. Tripathi, S.

Comparative efficacy of leading COVID-19 vaccines: A netwometa-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Ma, K. Christensen, M. Turnbull, M.

Comparative synthesis of sociocultural and political influences (SPIs) on COVID-19 vaccine hesitancy: an interdisciplinary systematic review

  • Adults
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Samal, J. Preetha, G. S. Kumar, R. P. Lakshman, N. Dehury, R. K. Singh, H.

Coronavirus Disease 2019 Vaccine Hesitancy and Acceptance among the Indian Population: A Systematic Review and Meta-Analysis

  • South-East Asia
  • India
  • Adolescents
  • Adults
  • Older adults
  • Healthcare workers
  • Parents/caregivers
  • Pregnant women
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
Loading...